Pro/Con debate: Are barrier precautions cost-effective in improving patient outcomes in the intensive care unit?

Critical Care

Volumn 16, Issue 1, 2011, Pages

  Thampi, Nisha ^a   Morris, Andrew M ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; EMERGENCY WARD; HEALTH CARE COST; HEALTH CARE QUALITY; HOSPITAL INFECTION; HOSPITAL MANAGEMENT; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INTENSIVE CARE UNIT; INTUBATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; PATIENT CARE; PNEUMONIA; PRIORITY JOURNAL; PROTECTIVE EQUIPMENT; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; TREATMENT OUTCOME; UNITED STATES; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 84856020858     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10532     Document Type: Review

References (47)

1. Langmuir AD. The Epidemic Intelligence Service of the Center for Disease Control. Public Health Rep 1980, 95:470-477. 1422746, 6106957.
2. Gould IM. Alexander Gordon, puerperal sepsis, and modern theories of infection control - Semmelweis in perspective. Lancet Infect Dis 2010, 10:275-278. 10.1016/S1473-3099(09)70304-4, 20334850.
3. Holmes O. The contagiousness of puerperal fever. N Engl Q J Med Surg 1843, 1:501-530.
4. Newsom SW. Pioneers in infection control. Ignaz Philipp Semmelweis. J Hosp Infect 1993, 23:175-187. 10.1016/0195-6701(93)90023-S, 8099092.
5. Nightingale F. Notes on Nursing: What It Is, and What It Is Not 1859, London: Harrison, 1.
6. Aboelela SW, Saiman L, Stone P, Lowy FD, Quiros D, Larson E. Effectiveness of barrier precautions and surveillance cultures to control transmission of multidrug-resistant organisms: a systematic review of the literature. Am J Infect Control 2006, 34:484-494. 10.1016/j.ajic.2006.03.008, 17015153.
7. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994, 271:1598-1601. 10.1001/jama.1994.03510440058033, 8182812.
8. Burgmann H, Hiesmayr JM, Savey A, Bauer P, Metnitz B, Metnitz PG. Impact of nosocomial infections on clinical outcome and resource consumption in critically ill patients. Intensive Care Med 2010, 36:1597-1601. 10.1007/s00134-010-1941-2, 20614212.
9. Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999, 27:520-532. Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services.
10. Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan T, Gaynes R. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 2006, 42:389-391. 10.1086/499367, 16392087.
11. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003, 36:53-59. 10.1086/345476, 12491202.
12. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, Briggs JP, Sexton DJ, Kaye KS. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003, 36:592-598. 10.1086/367653, 12594640.
13. Jernigan JA, Titus MG, Groschel DH, Getchell-White S, Farr BM. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996, 143:496-504.
14. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003, 24:362-386. 10.1086/502213, 12785411.
15. Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. JAMA 2009, 301:727-736. 10.1001/jama.2009.153, 19224749.
16. Doebbeling BN, Stanley GL, Sheetz CT, Pfaller MA, Houston AK, Annis L, Li N, Wenzel RP. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992, 327:88-93. 10.1056/NEJM199207093270205, 1285746.
17. Pittet D, Hugonnet S, Harbarth S, Mourouga P, Sauvan V, Touveneau S, Perneger TV. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 2000, 356:1307-1312. 10.1016/S0140-6736(00)02814-2, 11073019.
18. Rosenthal VD, Guzman S, Safdar N. Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. Am J Infect Control 2005, 33:392-397. 10.1016/j.ajic.2004.08.009, 16153485.
19. Srinivasan A, Song X, Ross T, Merz W, Brower R, Perl TM. A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit. Infect Control Hosp Epidemiol 2002, 23:424-428. 10.1086/502079, 12186206.
20. Puzniak LA, Leet T, Mayfield J, Kollef M, Mundy LM. To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci. Clin Infect Dis 2002, 35:18-25. 10.1086/340739, 12060870.
21. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G, Bander J, Kepros J, Goeschel C. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006, 355:2725-2732. 10.1056/NEJMoa061115, 17192537.
22. Jain R, Kralovic SM, Evans ME, Ambrose M, Simbartl LA, Obrosky DS, Render ML, Freyberg RW, Jernigan JA, Muder RR, Miller LJ, Roselle GA. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 2011, 364:1419-1430. 10.1056/NEJMoa1007474, 21488764.
23. Huang SS, Yokoe DS, Hinrichsen VL, Spurchise LS, Datta R, Miroshnik I, Platt R. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006, 43:971-978. 10.1086/507636, 16983607.
24. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982, 97:309-317.
25. Pan A, Carnevale G, Catenazzi P, Colombini P, Crema L, Dolcetti L, Ferrari L, Mondello P, Signorini L, Tinelli C, Roldan EQ, Carosi G. Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA 'search and isolate' strategy in a hospital in Italy with hyperendemic MRSA. Infect Control Hosp Epidemiol 2005, 26:127-133. 10.1086/502515, 15756881.
26. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999, 160:976-981.
27. Kirkland KB, Weinstein JM. Adverse effects of contact isolation. Lancet 1999, 354:1177-1178. 10.1016/S0140-6736(99)04196-3, 10513715.
28. Gagne D, Bedard G, Maziade PJ. Systematic patients' hand disinfection: impact on methicillin-resistant Staphylococcus aureus infection rates in a community hospital. J Hosp Infect 2010, 75:269-272. 10.1016/j.jhin.2010.02.028, 20434796.
29. Karchmer TB, Durbin LJ, Simonton BM, Farr BM. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2002, 51:126-132. 10.1053/jhin.2002.1200, 12090800.
30. Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999, 282:1745-1751. 10.1001/jama.282.18.1745, 10568647.
31. Muto CA, Giannetta ET, Durbin LJ, Simonton BM, Farr BM. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2002, 23:429-435. 10.1086/502080, 12186207.
32. Montecalvo MA, Jarvis WR, Uman J, Shay DK, Petrullo C, Horowitz HW, Wormser GP. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting. Infect Control Hosp Epidemiol 2001, 22:437-442. 10.1086/501931, 11583213.
33. Saint S, Higgins LA, Nallamothu BK, Chenoweth C. Do physicians examine patients in contact isolation less frequently? A brief report. Am J Infect Control 2003, 31:354-356. 10.1016/S0196-6553(02)48250-8, 14608302.
34. Evans HL, Shaffer MM, Hughes MG, Smith RL, Chong TW, Raymond DP, Pelletier SJ, Pruett TL, Sawyer RG. Contact isolation in surgical patients: a barrier to care?. Surgery 2003, 134:180-188. 10.1067/msy.2003.222, 12947316.
35. Maunder R, Hunter J, Vincent L, Bennett J, Peladeau N, Leszcz M, Sadavoy J, Verhaeghe LM, Steinberg R, Mazzulli T. The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital. CMAJ 2003, 168:1245-1251. 154178, 12743065.
36. Nickell LA, Crighton EJ, Tracy CS, Al-Enazy H, Bolaji Y, Hanjrah S, Hussain A, Makhlouf S, Upshur RE. Psychosocial effects of SARS on hospital staff: survey of a large tertiary care institution. CMAJ 2004, 170:793-798. 10.1503/cmaj.1031077, 343853, 14993174.
37. Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA 2003, 290:1899-1905. 10.1001/jama.290.14.1899, 14532319.
38. Koss WG, Khalili TM, Lemus JF, Chelly MM, Margulies DR, Shabot MM. Nosocomial pneumonia is not prevented by protective contact isolation in the surgical intensive care unit. Am Surg 2001, 67:1140-1144.
39. Loeb M, Dafoe N, Mahony J, John M, Sarabia A, Glavin V, Webby R, Smieja M, Earn DJ, Chong S, Webb A, Walter SD. Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA 2009, 302:1865-1871. 10.1001/jama.2009.1466, 19797474.
40. Johnson DF, Druce JD, Birch C, Grayson ML. A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection. Clin Infect Dis 2009, 49:275-277. 10.1086/600041, 19522650.
41. Gralton J, McLaws ML. Protecting healthcare workers from pandemic influenza: N95 or surgical masks?. Crit Care Med 2010, 38:657-667. 10.1097/CCM.0b013e3181b9e8b3, 20095070.
42. Bonten MJ, Slaughter S, Ambergen AW, Hayden MK, van Voorhis J, Nathan C, Weinstein RA. The role of 'colonization pressure' in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998, 158:1127-1132. 10.1001/archinte.158.10.1127, 9605785.
43. Slaughter S, Hayden MK, Nathan C, Hu TC Rice T, Van Voorhis J, Matushek M, Franklin C, Weinstein RA. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996, 125:448-456.
44. Huskins WC, Huckabee CM, O'Grady NP, Murray P, Kopetskie H, Zimmer L, Walker ME, Sinkowitz-Cochran RL, Jernigan JA, Samore M, Wallace D, Goldmann DA. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 2011, 364:1407-1418. 10.1056/NEJMoa1000373, 21488763.
45. Cohen E, Austin J, Weinstein M, Matlow A, Redelmeier DA. Care of children isolated for infection control: a prospective observational cohort study. Pediatrics 2008, 122:e411-e415. 10.1542/peds.2008-0181, 18676528.
46. Wenzel RP, Nettleman MD, Jones RN, Pfaller MA. Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures. Am J Med 1991, 91:221S-227S. 10.1016/0002-9343(91)90372-5, 1928168.
47. Siegel JD, Rhinehart E, Jackson M, Chiarello L, . the Healthcare Infection Control Practices Advisory Committee Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. 2007, [http://www.cdc.gov/hicpac/2007IP/2007isolationPrecautions.html] last accessed November 24, 2011, the Healthcare Infection Control Practices Advisory Committee.